Klivira
Request demo

Navigating UnitedHealthcare Epclusa Prior Authorization

Efficiently managing UnitedHealthcare Epclusa prior authorization is critical for timely patient access to this essential Hepatitis C treatment. Klivira automates the complex workflows involved, reducing administrative burden.

Epclusa (sofosbuvir/velpatasvir) is a direct-acting antiviral medication used to treat chronic Hepatitis C virus (HCV) infection across various genotypes. As a high-cost specialty drug, it routinely requires prior authorization (PA) from UnitedHealthcare across its commercial, Medicare Advantage, and Medicaid managed care plans. Understanding UnitedHealthcare's specific requirements and submission pathways is key to minimizing delays and denials.

UnitedHealthcare's Prior Authorization Channels for Epclusa

For specialty medications like Epclusa, UnitedHealthcare leverages OptumRx, its pharmacy benefit manager (PBM), for pharmacy benefit prior authorizations. Prescriber-initiated retail pharmacy PA submissions for Epclusa can route through OptumRx's provider PA system or through established ePA partners such as CoverMyMeds and Surescripts. For medical benefit coverage of specialty injectables or infusions, the UnitedHealthcare Provider Portal at uhcprovider.com is the primary channel, also accepting X12 278 transactions via clearinghouses.

Accessing Epclusa Medical Necessity Criteria

UnitedHealthcare publishes its medical necessity criteria and coverage rules, including those for specialty drugs, through its public Medical Policy Library. Revenue cycle teams should reference the specific drug policy number and effective date for Epclusa to understand clinical indications, step therapy requirements, and any quantity limits. UHC's commercial medical policies often state when criteria are based on external standards like MCG or NCCN compendium, which can inform documentation strategy.

Turnaround Times and Regulatory Compliance for Epclusa PAs

Prior authorization turnaround times for UnitedHealthcare vary by line of business and state regulations. Commercial PA timeframes are governed by state insurance laws. For Medicare Advantage and UnitedHealthcare Community Plan (Medicaid managed care) members, CMS-0057-F mandates 72-hour decisions for standard PA and 24-hour decisions for expedited PA, with a phased compliance timeline impacting electronic PA API conformance by 2027. Klivira helps track these timeframes to ensure compliance and prevent unnecessary delays.

Common Denial Reasons for Epclusa and Appeal Pathways

Denials for Epclusa prior authorizations typically stem from issues such as insufficient clinical documentation, failure to meet medical necessity criteria, non-adherence to step therapy protocols, or off-label use without compendium support. UnitedHealthcare returns denial reasons via X12 277/835 transactions or portal status updates. The appeal pathway, documented in UHC's provider administrative guides, differs by line of business (commercial, MA, Medicaid), with peer-to-peer reviews available for clinical denials and expedited appeal options for urgent cases.

Klivira's Role in Optimizing UnitedHealthcare Epclusa PA

Klivira integrates directly with EMR systems and connects to payer portals like UHCprovider.com, as well as ePA partners such as CoverMyMeds and Surescripts, to automate the UnitedHealthcare Epclusa prior authorization process. Our platform streamlines submission, tracks status, and surfaces payer-specific requirements, helping your team proactively address potential denials and accelerate patient access to critical HCV treatment.

Frequently asked questions

Which UnitedHealthcare entity handles Epclusa prior authorizations?

For pharmacy benefit coverage, OptumRx, UnitedHealth Group's PBM, manages Epclusa prior authorizations, often routing through OptumRx's provider system or ePA partners like CoverMyMeds and Surescripts. If Epclusa were covered under the medical benefit (e.g., for certain specialty infusions), the UHCprovider.com portal would be the primary channel.

Where can I find UnitedHealthcare's medical necessity criteria for Epclusa?

UnitedHealthcare publishes its medical necessity criteria and coverage policies for specialty drugs, including Epclusa, in its public Medical Policy Library. It is crucial to review the specific policy number and effective date to understand the clinical requirements and documentation needed for approval.

Does UnitedHealthcare accept electronic prior authorization (ePA) for Epclusa?

Yes, for pharmacy benefit prior authorizations, UnitedHealthcare's PBM, OptumRx, supports ePA submissions through partners like CoverMyMeds and Surescripts. For medical benefit PAs, the UHCprovider.com portal is available, and X12 278 transactions are accepted via clearinghouses for applicable procedures.

What are common reasons for Epclusa PA denials by UnitedHealthcare?

Common denial reasons for Epclusa PAs include insufficient clinical documentation to demonstrate medical necessity, failure to meet UnitedHealthcare's specific criteria (e.g., genotype confirmation, liver fibrosis stage), non-compliance with step therapy requirements, or requests for off-label use without sufficient compendium support.

How does Klivira help with UnitedHealthcare Epclusa prior authorizations?

Klivira automates the UnitedHealthcare Epclusa prior authorization workflow by integrating with your EMR and connecting to UHC's various submission channels, including UHCprovider.com and ePA partners. Our platform streamlines documentation gathering, submission, status tracking, and helps identify payer-specific requirements to reduce manual effort and accelerate approvals.

Related coverage

Other epclusa prior authorization by payer

Other epclusa prior authorization by specialty

Ready to automate prior auth for this drug?

See how Klivira automates prior authorizations for your team.

Request a demo